Pigs ideal for assessing flu antibody therapies, say Pirbright scientists
Posted: 2 July, 2020
Studies undertaken at The Pirbright Institute in collaboration with Inovio Pharmaceuticals have shown that pigs can be used to assess whether influenza antibody therapies are effective, which could provide a better indication of their success in humans than small animal trials. They also demonstrated pigs are suitable for analysing the delivery systems used to administer the antibodies in order to provide longer lasting protection.